Immune checkpoint inhibitors: a promising choice for endometrial cancer patients?

L Musacchio, SM Boccia, G Caruso… - Journal of Clinical …, 2020 - mdpi.com
Although around 80% of endometrial cancers are diagnosed at early stages and present
with a 5-year survival rate exceeding 95%, patients with advanced and recurrent disease …

[HTML][HTML] Diagnostic value of microRNA panel in endometrial cancer: A systematic review

H Donkers, R Bekkers, K Galaal - Oncotarget, 2020 - ncbi.nlm.nih.gov
Purpose: We conducted a systematic review to evaluate the overall diagnostic accuracy of
miRNAs in detecting endometrial cancer. Materials and Methods: A systematic search of …

LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

S Wei, K Wang, X Huang, Z Zhao… - International journal of …, 2019 - journals.sagepub.com
This study was to investigate the expression correlation between long non-coding RNA
metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1), miR-200a-3p …

Development of biomarker signatures associated with anoikis to predict prognosis in endometrial carcinoma patients

S Chen, J Gu, Q Zhang, Y Hu, Y Ge - Journal of oncology, 2021 - Wiley Online Library
Purpose. To generate a signature based on anoikis‐related genes (ARGs) for endometrial
carcinoma (EC) patients and elucidate the molecular mechanisms in EC. Methods. On the …

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression

C Wang, F Kong, J Ma, J Miao, P Su, H Yang, Q Li… - Cell death …, 2022 - nature.com
Long noncoding RNAs (lncRNAs) play important regulatory roles in a variety of pathological
processes involving cancer. However, the exact molecular mechanisms of lncRNA …

Endometrial cancer stem cells: where do we stand and where should we go?

C Banz-Jansen, LP Helweg, B Kaltschmidt - International Journal of …, 2022 - mdpi.com
Endometrial cancer is one of the most common malignant diseases in women worldwide,
with an incidence of 5.9%. Thus, it is the most frequent cancer of the female genital tract, with …

[HTML][HTML] Long non-coding RNAs and endometrial cancer

H Liu, J Wan, J Chu - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Endometrial cancer (EC) is one of the most common gynecologic malignancies. In spite of
the advance in chemotherapy, radiotherapy or surgical techniques for EC in recent years …

The role of immunohistochemistry markers in endometrial cancer with mismatch repair deficiency: a systematic review

A Favier, J Varinot, C Uzan, A Duval, I Brocheriou… - Cancers, 2022 - mdpi.com
Simple Summary Identification of mismatch repair-deficient tumors (MMRd), which occur in
up to 30% of all endometrial cancers (EC), has become unavoidable for therapeutic …

Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer

W Huang, F Kong, R Li, X Chen, K Wang - Frontiers in Oncology, 2022 - frontiersin.org
Gynecological cancers seriously affect the reproductive system of females; diseases include
ovarian tumors, uterine tumors, endometrial cancers, cervical cancers, and vulva and …

Extraterrestrial gynecology: could spaceflight increase the risk of developing cancer in female astronauts? An updated review

R Drago-Ferrante, R Di Fiore, F Karouia… - International journal of …, 2022 - mdpi.com
Outer space is an extremely hostile environment for human life, with ionizing radiation from
galactic cosmic rays and microgravity posing the most significant hazards to the health of …